Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2015

Open Access 01-12-2015 | Research article

Ventilatory abnormalities in patients with cystic fibrosis undergoing the submaximal treadmill exercise test

Authors: Paloma Lopes Francisco Parazzi, Fernando Augusto de Lima Marson, Maria Angela Gonçalves de Oliveira Ribeiro, Celize Cruz Bresciani de Almeida, Luiz Cláudio Martins, Ilma Aparecida Paschoal, Adyleia Aparecida Dalbo Contrera Toro, Camila Isabel Santos Schivinski, Jose Dirceu Ribeiro

Published in: BMC Pulmonary Medicine | Issue 1/2015

Login to get access

Abstract

Background

Exercise has been studied as a prognostic marker for patients with cystic fibrosis (CF), as well as a tool for improving their quality of life and analyzing lung disease. In this context, the aim of the present study was to evaluate and compare variables of lung functioning. Our data included: (i) volumetric capnography (VCAP) parameters: expiratory minute volume (VE), volume of exhaled carbon dioxide (VCO2), VE/VCO2, ratio of dead space to tidal volume (VD/VT), and end-tidal carbon dioxide (PetCO2); (ii) spirometry parameters: forced vital capacity (FVC), percent forced expiratory volume in the first second of the FVC (FEV1%), and FEV1/FVC%; and (iii) cardiorespiratory parameters: heart rate (HR), respiratory rate, oxygen saturation (SpO2), and Borg scale rating at rest and during exercise. The subjects comprised children, adolescents, and young adults aged 6–25 years with CF (CF group [CFG]) and without CF (control group [CG]).

Methods

This was a clinical, prospective, controlled study involving 128 male and female patients (64 with CF) of a university hospital. All patients underwent treadmill exercise tests and provided informed consent after study approval by the institutional ethics committee. Linear regression, Kruskal–Wallis test, and Mann–Whitney test were performed to compare the CFG and CG. The α value was set at 0.05.

Results

Patients in the CFG showed significantly different VCAP values and spirometry variables throughout the exercise test. Before, during, and after exercise, several variables were different between the two groups; statistically significant differences were seen in the spirometry parameters, SpO2, HR, VCO2, VE/VCO2, PetCO2, and Borg scale rating. VCAP variables changed at each time point analyzed during the exercise test in both groups.

Conclusion

VCAP can be used to analyze ventilatory parameters during exercise. All cardiorespiratory, spirometry, and VCAP variables differed between patients in the CFG and CG before, during, and after exercise.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rand S, Prasad A. Exercise as part of a cystic fibrosis therapeutic routine. Expert Rev Respir Med. 2012;6 Suppl 3:341–52.CrossRefPubMed Rand S, Prasad A. Exercise as part of a cystic fibrosis therapeutic routine. Expert Rev Respir Med. 2012;6 Suppl 3:341–52.CrossRefPubMed
3.
go back to reference Bernardi DM, Ribeiro AF, Mazzola TN, Vilela MMS, Sgarbieri VC. The impact of cystic fibrosis on the immunologic profile of pediatric patients. J Pediatr. 2013;89 Suppl 1:40–7.CrossRef Bernardi DM, Ribeiro AF, Mazzola TN, Vilela MMS, Sgarbieri VC. The impact of cystic fibrosis on the immunologic profile of pediatric patients. J Pediatr. 2013;89 Suppl 1:40–7.CrossRef
4.
go back to reference Chaves CRMM, Oliveira CQ, Britto JAA, Elsas MICG. Exercise testing, aerobic and strength training for adolescents with cystic fibrosis: a literature review. Rev Bras Saúde Matern Infant. 2007;7 Suppl 3:245–50. Chaves CRMM, Oliveira CQ, Britto JAA, Elsas MICG. Exercise testing, aerobic and strength training for adolescents with cystic fibrosis: a literature review. Rev Bras Saúde Matern Infant. 2007;7 Suppl 3:245–50.
5.
6.
go back to reference Leeuwen PBVW, Arets HGM, Ent CKV, Beekman JM. Infection, inflammation and exercise in cystic fibrosis. Respir Res. 2013;14:32.CrossRef Leeuwen PBVW, Arets HGM, Ent CKV, Beekman JM. Infection, inflammation and exercise in cystic fibrosis. Respir Res. 2013;14:32.CrossRef
7.
go back to reference Elbasan B, Tunali N, Duzgun I, Ozcelik U. Effects of chest physiotherapy and aerobic exercise training on physical fitness in Young children with cystic fibrosis. Ital J Pediatr. 2012;38:2.CrossRefPubMedPubMedCentral Elbasan B, Tunali N, Duzgun I, Ozcelik U. Effects of chest physiotherapy and aerobic exercise training on physical fitness in Young children with cystic fibrosis. Ital J Pediatr. 2012;38:2.CrossRefPubMedPubMedCentral
8.
go back to reference Pereira FM, Ribeiro MAGO, Ribeiro AF, Toro AADC, Hessel G, Ribeiro JD. Functional performance on the six-minute walk test in patients with cystic fibrosis. J Bras Pneumol. 2011;37 Suppl 6:735–44.PubMed Pereira FM, Ribeiro MAGO, Ribeiro AF, Toro AADC, Hessel G, Ribeiro JD. Functional performance on the six-minute walk test in patients with cystic fibrosis. J Bras Pneumol. 2011;37 Suppl 6:735–44.PubMed
9.
go back to reference Silva OB, Filho DCS. A new proposal to guide velocity and inclination in the ramp protocol for the treadmill ergometer. Arq Bras Cardiol. 2003;81 Suppl 1:42–7. Silva OB, Filho DCS. A new proposal to guide velocity and inclination in the ramp protocol for the treadmill ergometer. Arq Bras Cardiol. 2003;81 Suppl 1:42–7.
10.
go back to reference Ferrazza AM, Martolini D, Valli G, Palange P. Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases. Respiration. 2009;77 Suppl 1:3–17.CrossRefPubMed Ferrazza AM, Martolini D, Valli G, Palange P. Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases. Respiration. 2009;77 Suppl 1:3–17.CrossRefPubMed
12.
go back to reference Wolff G, Brunner JK. Series dead space volume assessed as the mean value of a distribution function. Int J Clin Monit Comp. 1984;1:177–81.CrossRef Wolff G, Brunner JK. Series dead space volume assessed as the mean value of a distribution function. Int J Clin Monit Comp. 1984;1:177–81.CrossRef
13.
go back to reference Fletcher R, Jonson B. Dead space and the single breath test carbon dioxide during anaesthesia and artificial ventilation. Br J Anasth. 1984;6:109–76.CrossRef Fletcher R, Jonson B. Dead space and the single breath test carbon dioxide during anaesthesia and artificial ventilation. Br J Anasth. 1984;6:109–76.CrossRef
14.
go back to reference Toulou PP. Distribution of ventilation: clinical evaluation by rapid CO2 analysis. Chest. 1996;49:139–45. Toulou PP. Distribution of ventilation: clinical evaluation by rapid CO2 analysis. Chest. 1996;49:139–45.
15.
go back to reference Smidt U. Emphysema as possible explanation for the alteration of PO2 and PCO2 curves. Bull Eur Physiopathol Respir. 1976;12:607–24. Smidt U. Emphysema as possible explanation for the alteration of PO2 and PCO2 curves. Bull Eur Physiopathol Respir. 1976;12:607–24.
16.
go back to reference Worth H. Expiratory partial pressure curves in the diagnostic of emphysema. Bull Eur Physiopathol Respir. 1986;22:191–9.PubMed Worth H. Expiratory partial pressure curves in the diagnostic of emphysema. Bull Eur Physiopathol Respir. 1986;22:191–9.PubMed
17.
go back to reference Davis JA, Sorrentino KM, Ninness EM, Pham PH, Dorado S, Costello KB. Test-retest reliability for two indices of ventilatory efficiency measured during cardiopulmonary exercise testing in healthy men and women. Clin Physiol Funct Imaging. 2006;26 Suppl 3:191–6.CrossRefPubMed Davis JA, Sorrentino KM, Ninness EM, Pham PH, Dorado S, Costello KB. Test-retest reliability for two indices of ventilatory efficiency measured during cardiopulmonary exercise testing in healthy men and women. Clin Physiol Funct Imaging. 2006;26 Suppl 3:191–6.CrossRefPubMed
18.
go back to reference Tumminello G, Guazzi M, Lancellotti P, Pie’rard L. Exercise ventilation inefficiency in heart failure: pathophysiological and clinical significance. Eur Heart J. 2007;28:673–8.CrossRefPubMed Tumminello G, Guazzi M, Lancellotti P, Pie’rard L. Exercise ventilation inefficiency in heart failure: pathophysiological and clinical significance. Eur Heart J. 2007;28:673–8.CrossRefPubMed
19.
go back to reference Ribeiro MA, Silva MT, Ribeiro JD, Moreira MM, Almeida CC, Almeida-Junior AA, et al. Volumetric capnography as a tool to detect early peripheric lung obstruction in cystic fibrosis patients. J Pediatr. 2012;88 Suppl 6:509–17.CrossRef Ribeiro MA, Silva MT, Ribeiro JD, Moreira MM, Almeida CC, Almeida-Junior AA, et al. Volumetric capnography as a tool to detect early peripheric lung obstruction in cystic fibrosis patients. J Pediatr. 2012;88 Suppl 6:509–17.CrossRef
20.
go back to reference Ribeiro JD, Ribeiro MAGO, Ribeiro AF. Controversies in cystic fibrosis – from pediatrician to specialist. J Pediatr (Rio J). 2002;78 Suppl 2:S171–86.CrossRef Ribeiro JD, Ribeiro MAGO, Ribeiro AF. Controversies in cystic fibrosis – from pediatrician to specialist. J Pediatr (Rio J). 2002;78 Suppl 2:S171–86.CrossRef
21.
go back to reference Döring G, Conway SP, Heijerman HG, Hodson ME, Høiby N, Smyth A, et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J. 2000;16(4):749–67.CrossRefPubMed Döring G, Conway SP, Heijerman HG, Hodson ME, Høiby N, Smyth A, et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J. 2000;16(4):749–67.CrossRefPubMed
22.
go back to reference Coelho CC, Aquino Eda S, de Almeida DC, Oliveira GC, Pinto RC, Rezende IM, et al. Comparative analysis and reproducibility of the modified shuttle walk test in normal children and in children with cystic fibrosis. J Bras Pneumol. 2007;33(2):168–74.CrossRefPubMed Coelho CC, Aquino Eda S, de Almeida DC, Oliveira GC, Pinto RC, Rezende IM, et al. Comparative analysis and reproducibility of the modified shuttle walk test in normal children and in children with cystic fibrosis. J Bras Pneumol. 2007;33(2):168–74.CrossRefPubMed
23.
go back to reference CFF. Cystic Fibrosis Foundation, Patient Registry 2002 Annual Data Report. Bethesda, Maryland: Patient Registry; 2002. CFF. Cystic Fibrosis Foundation, Patient Registry 2002 Annual Data Report. Bethesda, Maryland: Patient Registry; 2002.
24.
go back to reference Kanga J, Kuhn R, Craigmyle, Haverstock D, Church D. Cystic Fibrosis clinical score: a new scoring system to evalute acute pulmonary exacerbation. Clin Ther. 1999;21:1343–56.CrossRefPubMed Kanga J, Kuhn R, Craigmyle, Haverstock D, Church D. Cystic Fibrosis clinical score: a new scoring system to evalute acute pulmonary exacerbation. Clin Ther. 1999;21:1343–56.CrossRefPubMed
25.
go back to reference ATS – American Thoracic Society. ATS Statement: guidelines for the sixminute walk test. Am J Respir Crit Care Med. 2002;166:111–7.CrossRef ATS – American Thoracic Society. ATS Statement: guidelines for the sixminute walk test. Am J Respir Crit Care Med. 2002;166:111–7.CrossRef
26.
go back to reference Schneiderman-Walker J, Coates AL. Does carbon dioxide retention during exercise predict a more rapid decline in FEV1 in cystic fibrosis? Arch Dis Child. 2005;90 Suppl 8:792–5.PubMed Schneiderman-Walker J, Coates AL. Does carbon dioxide retention during exercise predict a more rapid decline in FEV1 in cystic fibrosis? Arch Dis Child. 2005;90 Suppl 8:792–5.PubMed
27.
go back to reference Leroy S, Perez T, Neviere R, Aquilanju B, Wallaert B. Determinants of dyspnea and alveolar hypoventilation during exercise in cystic fibrosis: Impact of inspiratory muscle endurance. J Cyst Fibros. 2011;10 Suppl 3:159–65.CrossRefPubMed Leroy S, Perez T, Neviere R, Aquilanju B, Wallaert B. Determinants of dyspnea and alveolar hypoventilation during exercise in cystic fibrosis: Impact of inspiratory muscle endurance. J Cyst Fibros. 2011;10 Suppl 3:159–65.CrossRefPubMed
28.
go back to reference Pianosi P, Hochman J. End-tidal estimates of arterial PCO2 for cardiac output measurement by CO2 rebreathing: a study in patients with cystic fibrosis and healthy controls. Pediatr Pulmonol. 1996;22 Suppl 3:154–60.CrossRefPubMed Pianosi P, Hochman J. End-tidal estimates of arterial PCO2 for cardiac output measurement by CO2 rebreathing: a study in patients with cystic fibrosis and healthy controls. Pediatr Pulmonol. 1996;22 Suppl 3:154–60.CrossRefPubMed
29.
go back to reference Paranjape SM, Barnes LA, Carson KA, Von Berg K, Loosen H, Mogayzel Jr PJ. Exercise improves lung function and habitual activity in children with cystic fibrosis. J Cyst Fibros. 2012;11 Suppl 1:18–23.CrossRefPubMed Paranjape SM, Barnes LA, Carson KA, Von Berg K, Loosen H, Mogayzel Jr PJ. Exercise improves lung function and habitual activity in children with cystic fibrosis. J Cyst Fibros. 2012;11 Suppl 1:18–23.CrossRefPubMed
30.
go back to reference Fuchs SI, Junge S, Ellemunter H, Ballmann M, Gappa M. Calculation of the capnographic index based on expiratory molar mass-volume-curves-a suitable tool to screen for cystic fibrosis lung disease. J Cyst Fibrosis. 2013;12 Suppl 3:277–83.CrossRef Fuchs SI, Junge S, Ellemunter H, Ballmann M, Gappa M. Calculation of the capnographic index based on expiratory molar mass-volume-curves-a suitable tool to screen for cystic fibrosis lung disease. J Cyst Fibrosis. 2013;12 Suppl 3:277–83.CrossRef
31.
go back to reference Veronez L, Moreira MM, Soares ST, Pereira MC, Ribeiro MA, Ribeiro JD, et al. Volumetric capnography for the evaluation of pulmonary disease in adult patients with cystic fibrosis and noncystic fibrosis bronchiectasis. Lung. 2010;188 Suppl 3:263–8.CrossRefPubMed Veronez L, Moreira MM, Soares ST, Pereira MC, Ribeiro MA, Ribeiro JD, et al. Volumetric capnography for the evaluation of pulmonary disease in adult patients with cystic fibrosis and noncystic fibrosis bronchiectasis. Lung. 2010;188 Suppl 3:263–8.CrossRefPubMed
32.
go back to reference Holland AE, Rasekaba T, Wilson JW, Button BM. Desaturation during the 3-minute step test predicts impaired 12-month outcomes in adult patients wh cystic fibrosis. Respir Care. 2011;56 Suppl 8:1137–42.CrossRefPubMed Holland AE, Rasekaba T, Wilson JW, Button BM. Desaturation during the 3-minute step test predicts impaired 12-month outcomes in adult patients wh cystic fibrosis. Respir Care. 2011;56 Suppl 8:1137–42.CrossRefPubMed
33.
go back to reference Marcus BH, Williams DM, Dubbert PM, Sallis JF, King AC, Yancey AK, et al. Physical activity intervention studies: what we know and what we need to know. Circulation. 2006;114(24):2739–52.CrossRefPubMed Marcus BH, Williams DM, Dubbert PM, Sallis JF, King AC, Yancey AK, et al. Physical activity intervention studies: what we know and what we need to know. Circulation. 2006;114(24):2739–52.CrossRefPubMed
34.
go back to reference Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004;364 Suppl 9435:709–21.CrossRefPubMed Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004;364 Suppl 9435:709–21.CrossRefPubMed
35.
go back to reference Calverley PMA, Koulouris NG. Flow limitation and dynamic hyperinsuflation: key concepts in modern respiratory physiology. Eur Respir J. 2005;25(1):186–99.CrossRefPubMed Calverley PMA, Koulouris NG. Flow limitation and dynamic hyperinsuflation: key concepts in modern respiratory physiology. Eur Respir J. 2005;25(1):186–99.CrossRefPubMed
36.
go back to reference Hibbert A, Lanning A, Raven J, Landau L, Phelan P. Gender differences in lung growth. Pediatr Pulmonol. 1995;19:129–34.CrossRefPubMed Hibbert A, Lanning A, Raven J, Landau L, Phelan P. Gender differences in lung growth. Pediatr Pulmonol. 1995;19:129–34.CrossRefPubMed
Metadata
Title
Ventilatory abnormalities in patients with cystic fibrosis undergoing the submaximal treadmill exercise test
Authors
Paloma Lopes Francisco Parazzi
Fernando Augusto de Lima Marson
Maria Angela Gonçalves de Oliveira Ribeiro
Celize Cruz Bresciani de Almeida
Luiz Cláudio Martins
Ilma Aparecida Paschoal
Adyleia Aparecida Dalbo Contrera Toro
Camila Isabel Santos Schivinski
Jose Dirceu Ribeiro
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2015
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-015-0056-5

Other articles of this Issue 1/2015

BMC Pulmonary Medicine 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.